ArticleJournal of imaging informatics in medicine2024
Res-TransNet: A Hybrid deep Learning Network for Predicting Pathological Subtypes of lung Adenocarcinoma in CT Images.
Article in Journal of imaging informatics in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and validation of a transformer-based deep learning model for predicting distant metastasis in non-small cell lung cancer usingClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- Robust Automatic Grading of Blunt Liver Trauma in Contrast-Enhanced Ultrasound Using Label-Noise-Resistant Models.Journal of imaging informatics in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aims to develop a CT-based hybrid deep learning network to predict pathological subtypes of early-stage lung adenocarcinoma by integrating residual network (ResNet) with Vision Transformer (ViT). A total of 1411 pathologically confirmed ground-glass nodules (GGNs) retrospectively collected from two centers were used as internal and external validation sets for model development. 3D ResNet and ViT were applied to investigate two deep learning frameworks to classify three subtypes of lung adenocarcinoma namely invasive adenocarcinoma (IAC), minimally invasive adenocarcinoma and adenocarcinoma in situ, respectively. To further improve the model performance, four Res-TransNet based models were proposed by integrating ResNet and ViT with different ensemble learning strategies. Two classification tasks involving predicting IAC from Non-IAC (Task1) and classifying three subtypes (Task2) were designed and conducted in this study. For Task 1, the optimal Res-TransNet model yielded area under the receiver operating characteristic curve (AUC) values of 0.986 and 0.933 on internal and external validation sets, which were significantly higher than that of ResNet and ViT models (p < 0.05). For Task 2, the optimal fusion model generated the accuracy and weighted F1 score of 68.3% and 66.1% on the external validation set. The experimental results demonstrate that Res-TransNet can significantly increase the classification performance compared with the two basic models and have the potential to assist radiologists in precision diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.